Zee Business Managing Editor Anil Singhvi shares his strategy for the January 5 session on Dalal Street. Learn more about his ...

If we learned one thing about Kazuma Okamoto on Tuesday, it’s that the man can draw a crowd. Packed inside the Blue Jays’ ...

Blue Jays must sign Kyle Tucker after Kazuma Okamoto addition to complete championship roster and maximize offensive ...

The Toronto Blue Jays unveiled Kazuma Okamoto on Tuesday, alongside his agent Scott Boras and general manager Ross Atkins, ...

Discover the 10 most expensive stock on the NSE as the stock market enters 2026 on a strong bullish streak, led by the ...

The 2025 MLB offseason has seen several high-profile players sign lucrative free-agent deals. However, four-time All-Star ...

With the news that the Toronto Blue Jays have signed third baseman Kazuma Okamoto out of the NPB, speculation quickly ...

Amgen has acquired U.K.-based biotechnology company Dark Blue Therapeutics in a transaction valued at up to $840 million. Amgen on Tuesday said the deal adds an investigational small molecule that ...

The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...

Blue-chip dividend stocks can offer income, returns and lower risk—but 2 trusted names may face a pullback. Read the full ...

A simple “sleep-better” TFSA core for January 2026 can start with a bank, a utility, and an energy blue chip, each doing a ...

Blue chips continued their strong start to the year on Tuesday with the FTSE 100 hitting a new record led by gains in retailer Next and drug stocks GSK and AstraZeneca. The FTSE 100 index closed up ...